Advertisement

Trends in the Uptake of Diagnostic Multi-Parametric MRI of the Prostate With Federal Funding: Australia Population Data

  • Gavin Wei
    Affiliations
    Department of Surgery, Austin Health, The University of Melbourne, Victoria, Australia
    Search for articles by this author
  • Nathan Papa
    Affiliations
    School of Public Health and Preventative Medicine, Monash University, Melbourne, Victoria, Australia
    Search for articles by this author
  • Brian Kelly
    Affiliations
    Department of Surgery, Austin Health, The University of Melbourne, Victoria, Australia
    Search for articles by this author
  • Damien Bolton
    Affiliations
    Department of Surgery, Austin Health, The University of Melbourne, Victoria, Australia

    Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Victoria, Australia
    Search for articles by this author
  • Marlon Perera
    Correspondence
    Address correspondence to: Marlon Perera, Department of Urology, Austin Health, Studley Road, Heidelberg, Victoria 3084, Australia.
    Affiliations
    Department of Surgery, Austin Health, The University of Melbourne, Victoria, Australia

    Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Victoria, Australia

    Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia
    Search for articles by this author
      In recent years, there has been an expanding role for multi-parametric Magnetic Resonance Imaging (mpMRI) in the workup of prostate cancer. There is growing evidence suggesting the utilization of mpMRI increases clinically significant prostate cancer detection and reduces prostate biopsy rates.
      • Becerra MF
      • Alameddine M
      • Zucker I
      • et al.
      Performance of multiparametric MRI of the prostate in biopsy naïve men: a meta-analysis of prospective studies.
      Furthermore, there are suggestions that mpMRI may help guide the management of patients with prostate cancer.
      • Perera M
      • Katelaris N
      • Murphy DG
      • McGrath S
      • Lawrentschuk N.
      Prostate imaging reporting and data system score of four or more: active surveillance no more.
      ,
      • Draulans C
      • Everaerts W
      • Isebaert S
      • et al.
      Impact of magnetic resonance imaging on prostate cancer staging and european association of urology risk classification.
      In keeping with this, the European Association of Urology prostate cancer guidelines now strongly recommend that mpMRI should be performed prior to biopsy.
      • Mottet N
      • van den Bergh RCN
      • Briers E
      • et al.
      EAU - ESTRO - ESUR - SIOG guidelines on prostate cancer 2020.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Becerra MF
        • Alameddine M
        • Zucker I
        • et al.
        Performance of multiparametric MRI of the prostate in biopsy naïve men: a meta-analysis of prospective studies.
        Urology. 2020; 146: 189-195
        • Perera M
        • Katelaris N
        • Murphy DG
        • McGrath S
        • Lawrentschuk N.
        Prostate imaging reporting and data system score of four or more: active surveillance no more.
        BJU Int. 2017; 119: 9-12
        • Draulans C
        • Everaerts W
        • Isebaert S
        • et al.
        Impact of magnetic resonance imaging on prostate cancer staging and european association of urology risk classification.
        Urology. 2019; 130: 113-119
        • Mottet N
        • van den Bergh RCN
        • Briers E
        • et al.
        EAU - ESTRO - ESUR - SIOG guidelines on prostate cancer 2020.
        European Association of Urology Guidelines. 2020 Edition. European Association of Urology Guidelines Office, Arnhem, The Netherlands2020 (Vol presented at the EAU Annual Congress Amsterdam 2020)
      1. Australian Government Department of Health. Medicare benefits schedule online 2020.

      2. Australian Government Department of Human Services. Medical item reports.

        • Roberts MJ
        • Papa N
        • Perera M
        • et al.
        A contemporary, nationwide analysis of surgery and radiotherapy treatment for prostate cancer.
        BJU Int. 2019; 124: 31-36